Therapeutic approaches to protein-misfolding diseases
Top Cited Papers
- 1 December 2003
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 426 (6968), 905-909
- https://doi.org/10.1038/nature02265
Abstract
Several sporadic and genetic diseases are caused by protein misfolding. These include cystic fibrosis and other devastating diseases of childhood as well as Alzheimer's, Parkinson's and other debilitating maladies of the elderly. A unified view of the molecular and cellular pathogenesis of these conditions has led to the search for chemical chaperones that can slow, arrest or revert disease progression. Molecules are now emerging that link our biophysical insights with our therapeutic aspirations.Keywords
This publication has 48 references indexed in Scilit:
- A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activityTrends in Pharmacological Sciences, 2003
- Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targetingAdvanced Drug Delivery Reviews, 2002
- Chemical chaperones increase the cellular activity of N370S β-glucosidase: A therapeutic strategy for Gaucher diseaseProceedings of the National Academy of Sciences, 2002
- Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturationThe EMBO Journal, 2002
- Alpha1-Antitrypsin Deficiency — A Model for Conformational DiseasesNew England Journal of Medicine, 2002
- Manipulating the Folding Pathway of ΔF508 CFTR Using Chemical ChaperonesPublished by Springer Nature ,2001
- Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutantsJournal of Clinical Investigation, 2000
- Amyloid fibrillogenesis: themes and variationsCurrent Opinion in Structural Biology, 2000
- Alternative conformations of amyloidogenic proteins govern their behaviorCurrent Opinion in Structural Biology, 1996
- Principles that Govern the Folding of Protein ChainsScience, 1973